Spots Global Cancer Trial Database for Prevalence of Hypogonadism in Male Cancer Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Prevalence of Hypogonadism in Male Cancer Patients
Official Title: Prevalence of Hypogonadism in Male Cancer Patients
Study ID: NCT00472940
Interventions
Study Description
Brief Summary: Cancer and its complications are common problems. In most cases, this condition has a profound impact on survival and quality of life (QoL). Fatigue, sexual dysfunction, decreased sexual drive, depression and poor appetite are commonly seen in these patients. However, these symptoms also are seen in men with other conditions including those with low testosterone levels. The objective of this study is to determine the number of male patients with cancer that have low testosterone levels and to establish the relationship between testosterone levels and the symptoms that these patients experience.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: Yes
Locations
Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, United States
Contact Details
Name: Jose M Garcia, MD
Affiliation: Baylor College of Medicine, Michael E. DeBakey VAMC
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
